Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

Ultrahypofractionated radiotherapy yields non-inferior 10-year survival outcomes compared to conventional treatment in ...

A trial evaluated the short-term oncologic efficacy of cooled focal therapy ablation using the ProFocal device in men with localized, intermediate-risk prostate cancer.

These results suggest that oxybutynin may offer a practical and effective option for managing ADT-associated hot flashes in ...

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...

WASHINGTON D.C. (WPVI) -- The Preventive Services Task Force is changing recommendations that can affect millions of middle-aged men. Five years ago, it opposed routine screening for prostate cancer, ...

Prostate cancer has overtaken breast cancer to become the most common form of the disease in the UK for the first time.